Exploring the Potential of Abexinostat as a Therapeutic Agent for Amyloid‐Beta Pathology in Alzheimer’s Disease: A Multimodal Approach
Abexinostat demonstrates potential as a dual-target therapeutic for AD, inhibiting Aβ aggregation and improving cognitive function by modulating oxidative stress and Aβ metabolism. Further investigation is needed to explore its clinical applications.
Authors
- Anik Das (ORCID: https://orcid.org/0009-0008-2602-8075)
- Lalit Sharma (ORCID: https://orcid.org/0000-0001-9855-704X)
Institutions
- Shoolini University (IN)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70859_096802
- Primary Topic
- Histone Deacetylase Inhibitors Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00